v3.26.1
Consolidated Statement of Changes in Shareholders’ Equity (Deficit) - USD ($)
Common Stock
Preferred Stock
Common Stock Issuable
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 276 $ 2,750 $ 281,682 $ 42,553,158 $ (42,033,136) $ 804,730
Balance (in Shares) at Dec. 31, 2023 2,762,055 2,750,000        
Sales of common stock $ 6 294,738 294,744
Sales of common stock (in Shares) 59,772          
Fair value of warrants allocated to proceeds of common stock 110,255 110,255
Fair value of warrants allocated to proceeds of related party debt 797,167 797,167
Fair value of beneficial conversion feature allocated to proceeds of related party debt 785,039 785,039
Shares and options issued to employees (283,869) 365,519 81,650
Shares and options issued to employees (in Shares) 50          
Consultant and director fees payable with common shares and warrants 157,819 157,819
Stock fees related to sales of common stock 6,000 (35,134) (29,134)
Net loss (6,131,479) (6,131,479)
Balance at Dec. 31, 2024 $ 282 $ 2,750 161,632 44,870,742 (48,164,615) (3,129,209)
Balance (in Shares) at Dec. 31, 2024 2,821,877 2,750,000        
Reclassification of historical amounts recognized for beneficial conversion features (915,826) 905,651 (10,175)
Sales of common stock 3,245 3,245
Sales of common stock (in Shares) 2,000          
Fair value of warrants allocated to proceeds of common stock 14,904 14,904
Fair value of beneficial conversion feature allocated to proceeds of related party debt 100,537 100,537
Forgiveness of related party debt 245,000 245,000
Fair value of stock options issued to reduce accounts payable 38,284 38,284
Shares and options issued to employees 109,550 109,550
Consultant and director fees payable with common shares and warrants $ 5 (80,000) 140,785 60,790
Consultant and director fees payable with common shares and warrants (in Shares) 49,558          
Stock fees related to sales of common stock $ 1 (20,283) 32,133 11,851
Stock fees related to sales of common stock (in Shares) 7,669          
Fair value of warrants to extend related party debt 73,626 73,626
Net loss (3,280,254) (3,280,254)
Balance at Dec. 31, 2025 $ 288 $ 2,750 $ 61,349 $ 44,712,980 $ (50,539,218) $ (5,761,851)
Balance (in Shares) at Dec. 31, 2025 2,881,104 2,750,000